Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $80.96M (100.0% shares, 0.0% debt)

Holdings (5)

ORIC ORIC Pharmaceuticals Inc. 52.5%

Value $42.49M Shares 3,540,777 Est. Cost $28.69 Unrealized -63.3%

— Surrozen, Inc. 23.9%

Value $19.33M Shares 1,499,773 Est. Cost $9.59 Unrealized —

TNYA Tenaya Therapeutics, Inc. 18.3%

Value $14.85M Shares 9,400,290 Est. Cost $21.49 Unrealized -95.3%

— RAPT Therapeutics Inc 5.3%

Value $4.283M Shares 166,075 Est. Cost $19.03 Unrealized —

RVMD Revolution Medicines Inc 0.0%

Value $2,148 Shares 46 Est. Cost $34.24 Unrealized +14.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$42.49M	52.5%	$28.69	-63.3%	COM	68622P109
—	Surrozen, Inc.	1,499,773	$19.33M	23.9%	$9.59	—	COM	86889P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$14.85M	18.3%	$21.49	-95.3%	COM	87990A106
—	RAPT Therapeutics Inc	166,075	$4.283M	5.3%	$19.03	—	COM	75382E109
RVMD	Revolution Medicines Inc	46	$2,148	0.0%	$34.24	+14.3%	COM	76155X100